Literature DB >> 30799824

Prevalence, treatment, and control of diabetes in a community setting in Ngaoundéré, Cameroon.

O Pancha Mbouemboue1, J O Ngoufack Tsougmo1, I Sakinatou1, A C Velinga Ndolok1, M Tangyi Tamanji2.   

Abstract

Diabetes imposes a heavy economic burden on low and middle-income countries. The aim of this work was to study the mean value of fasting blood glucose, as well as of the prevalence, awareness, treatment, and control of diabetes in Ngaoundere.
METHODOLOGY: This cross-sectional community-based study selected participants according to a three-level cluster sampling method. The variables measured were sociodemographic data, medical history, sleep duration, blood pressure, body mass index, abdominal perimeter, fasting blood glucose, and serum triglyceride and total cholesterol levels. Data were analyzed with SPSS 20.0 software.
RESULTS: The study included 948 participants aged 20 to 87 years. Their average fasting blood glucose was 0.85 ± 0.20 g/L. The prevalence of diabetes was 5.59%. It increased with age (p < 0.001), body mass index (p = 0.03), abdominal obesity (p = 0.041), hypertension (p < 0.001), and total cholesterol (p = 0.008). In the multivariate analysis, age greater than or equal to 65 years (p = 0.012) and hypertension (p = 0.001) were independently associated with diabetes. Most patients with diabetes (84.91%) were aware of their disease, but only 13.33% were receiving treatment, and the disease of only 50% of those treated was controlled.
CONCLUSION: In Ngaoundere, the prevalence of diabetes is 5.59 %, its control is poor, and its treatment rate is low.

Entities:  

Keywords:  Cameroon; awareness; diabetes; prevalence; treatment

Mesh:

Substances:

Year:  2018        PMID: 30799824     DOI: 10.1684/mst.2018.0851

Source DB:  PubMed          Journal:  Med Sante Trop        ISSN: 2261-3684


  1 in total

1.  Correlates of diabetic polyneuropathy of the elderly in Sub-Saharan Africa.

Authors:  Nadine Simo; Callixte Kuate-Tegueu; Steve Ngankou-Tchankeu; Jacques Doumbe; Youssoufa Maiga; Matteo Cesari; Jean-François Dartigues; Andre-Pascal Kengne; Maturin Tabue-Teguo
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.